High-Flying Biotech Stock 360% Faces Trim, Top Holding
A biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
Price weighting biases index behavior differently than market-cap methods. This overview explains the mechanics and the practical impact on portfolio results.
25,572 articlesA biotech stock that jumped 360% for investors is dealing with a big fund trim while staying the largest holding. Thi...
In a world of slim yields, five dividend stocks yielding more than 5% offer a chance for meaningful passive income. T...
A leading biotech-focused fund just boosted its Immunome position by a material amount as the stock surged. This arti...
Rivian surprised investors with higher-than-expected Q2 deliveries and a raised full-year delivery outlook. This arti...
In Buffett's final chapters as Berkshire's CEO, one move stood out: selling a stock that helped build his fortune. Th...
A new study links higher grocery costs to growing credit-card use at checkout, signaling widening financial strain fo...
Netflix backed away from a Warner Bros. deal, signaling a calculated shift in strategy. Here are five practical reaso...
Alphabet’s cloud momentum is reshaping the risk-and-reward profile for investors. This article explains why the googl...
For investors who want AI-driven growth without oversized risk, Nvidia offers a compelling path. This guide shows how...
A California court ruling affecting a rival studio triggered a risk-off mood that pulled down entertainment names, in...
Two AI-driven stocks are at the forefront of the tech shift. This guide explains how they shape future technology, wh...
NVIDIA just revealed owns a notable minority stake in Nebius, triggering a sharp stock move. This article breaks down...